FESK.COMYour global study desk
Email us
Home › Scholar › D. Van Luong
COMPILEDopen profilenot managed by this scholar
D

D. Van Luong

Researcher Profile 5/10
This is my profile

Information

Featured publications

LBA49 Associations of ctDNA clearance (CL) during neoadjuvant Tx with pathological response and event-free survival (EFS) in pts with resectable NSCLC (R-NSCLC): Expanded analyses from AEGEAN31 citations
Annals of Oncology · 2024 · DOI
OA12.05 Surgical Outcomes with Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC (AEGEAN)11 citations
Journal of Thoracic Oncology · 2023 · DOI
Voice Pathologies and the General Population’s Perception3 citations
Journal of Voice · 2023 · DOI
Phase I/II study of axitinib (axi) and nivolumab (nivo) in patients with metastatic renal cell carcinoma (mRCC).1 citations
Journal of Clinical Oncology · 2019 · DOI
Surgical outcomes with neoadjuvant Durvalumab+chemotherapy followed by adjuvant Durvalumab in resectable NSCLC (AEGEAN)
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie · 2024 · DOI

About the field of Medicine and Pharmacy

Common research topics in this field:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Institutions with the most researchers in this field:

These figures count profiles currently in this directory, not nationwide statistics.

The publication list above is compiled from the open academic database OpenAlex (CC0 licence). Compare with the source record on OpenAlex ↗

Suggest / Claim this profile

  
Profile aggregated from public sources. We respect scholars' rights to edit and remove information — all requests are processed promptly.
D. Van LuongHanoi Lung Hospital
Claim
Original profile stored athocthuat.vn— two pages display the same database, verification syncs everywhere.